Serum Metabolomic Profiles Identify ER-Positive Early Breast Cancer Patients at Increased Risk of Disease Recurrence in a Multicenter Population

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Clinical Cancer Research

• Publication date

  2017-01-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-16-1153PMID 28082280PMCID PMC5695865
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Luteal versus follicular phase surgical oophorectomy plus tamoxifen in premenopausal women with metastatic hormone receptor-positive breast cancer.

  2016cited by this paper
• Timing of adjuvant surgical oophorectomy in the menstrual cycle and disease-free and overall survival in premenopausal women with operable breast cancer.

  2015cited by this paper
• Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective study

  2015cited by this paper
• A serum nuclear magnetic resonance-based metabolomic signature of advanced metastatic human breast cancer.

  2014influential reference
• HMDB 3.0—The Human Metabolome Database in 2013

  2012cited by this paper
• Application of NMR metabolomics to search for human disease biomarkers.

  2012cited by this paper
• Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks

  2011cited by this paper
• Identification of a serum-detectable metabolomic fingerprint potentially correlated with the presence of micrometastatic disease in early breast cancer patients at varying risks of disease relapse by traditional prognostic methods.

  2011cited by this paper
• Early detection of recurrent breast cancer using metabolite profiling.

  2010cited by this paper
• Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.

  2010cited by this paper
• Early Detection of Recurrent Breast Cancer Using Metabolite Profiling

  2010cited by this paper
• Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts

  2007cited by this paper
• Metabolomics: available results, current research projects in breast cancer, and future applications.

  2007cited by this paper
• Classification and Regression by randomForest

  2007cited by this paper
• 30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study

  2005cited by this paper
• A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

  2004cited by this paper
• Random Forests

  2001cited by this paper
• Three-Dimensional Diffusion-Ordered NMR Spectroscopy: The Homonuclear COSY–DOSY Experiment

  1996cited by this paper
• Gentleman R: R: A language for data analysis and graphics

  1996cited by this paper
• Controlling the false discovery rate: a practical and powerful approach to multiple testing

  1995cited by this paper
• Automatic data reduction and pattern recognition methods for analysis of 1H nuclear magnetic resonance spectra of human urine from normal and pathological states.

  1994cited by this paper
• Automatic reduction of NMR spectroscopic data for statistical and pattern recognition classification of samples.

  1994cited by this paper
• The Distribution of the Generalized Variance

  1965cited by this paper
• Modified Spin‐Echo Method for Measuring Nuclear Relaxation Times

  1958cited by this paper
• Individual Comparisons by Ranking Methods

  1945cited by this paper

• RBC balanced immuno-inflammatory signatures identify advanced breast cancer patients on CDK4/6 inhibitors at increased risk of progression and death

  2025cites this paper
• Deriving three one dimensional NMR spectra from a single experiment through machine learning

  2025cites this paper
• A Robust Multivariate Approach Unveils a 1H-NMR-Based Spectral Metabolomics Signature Predictive of Cardiovascular Disease in People with Type 2 Diabetes: A Prospective Di@bet.es Cohort Study.

  2025cites this paper
• Serum metabolite and metal ions profiles for breast cancer screening

  2024influential citation
• Metabolomic Profiling of Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy for Predicting Disease-Free and Overall Survival

  2024cites this paper
• Biomarker discovery and development of prognostic prediction model using metabolomic panel in breast cancer patients: a hybrid methodology integrating machine learning and explainable artificial intelligence

  2024cites this paper
• In Vitro MRS of Cells Treated with Trastuzumab at 1.5 Tesla

  2024cites this paper
• Metabolomics assisted by transcriptomics analysis to reveal metabolic characteristics and potential biomarkers associated with treatment response of neoadjuvant therapy with TCbHP regimen in HER2 + breast cancer

  2024cites this paper
• Identification of metabolic pathways contributing to ER+ breast cancer disparities using a machine-learning pipeline

  2023cites this paper
• DECODING THE ENDOGENOUS METABOLOME OF BREAST CANCER: ANALYTICAL APPROACHES AND CHEMOMETRIC INTERVENTION. A SYSTEMATIC REVIEW

  2023cites this paper
• Fingerprinting and profiling in metabolomics of biosamples.

  2023cites this paper
• The Role of Amino Acids in the Diagnosis, Risk Assessment, and Treatment of Breast Cancer: A Review

  2023cites this paper
• Comparison of phenomics and cfDNA in a large breast screening population: the Breast Screening and Monitoring Study (BSMS)

  2023cites this paper
• Diagnosis and prognosis of breast cancer by high-performance serum metabolic fingerprints

  2022cites this paper
• Shifting-corrected regularized regression for 1H NMR metabolomics identification and quantification.

  2022cites this paper
• Two effective models based on comprehensive lipidomics and metabolomics can distinguish BC versus HCs, and TNBC versus non‐TNBC

  2022cites this paper
• Risk assessment of disease recurrence in early breast cancer: A serum metabolomic study focused on elderly patients

  2022cites this paper
• NMR-Based Metabolomics to Evaluate Individual Response to Treatments.

  2022cites this paper
• An improved NMR approach for metabolomics of intact serum samples.

  2022cites this paper
• Metabolic Profiling of Bladder Cancer Patients’ Serum Reveals Their Sensitivity to Neoadjuvant Chemotherapy

  2022cites this paper
• Liquid biopsy markers for early diagnosis of brain metastasis patients with breast cancer by metabolomics

  2022cites this paper
• Magnetic Resonance Imaging (MRI) and MR Spectroscopic Methods in Understanding Breast Cancer Biology and Metabolism

  2022cites this paper
• Impact of the pre-examination phase on multicenter metabolomic studies.

  2022cites this paper
• Calcium Carbonate Core-Shell Particles for Incorporation of 225Ac and Their Application in Local α-Radionuclide Therapy.

  2021cites this paper
• Pharmacometabolomics by NMR in Oncology: A Systematic Review

  2021cites this paper
• Detection of Lung Cancer via Blood Plasma and 1H-NMR Metabolomics: Validation by a Semi-Targeted and Quantitative Approach Using a Protein-Binding Competitor

  2021cites this paper
• Lipid and metabolite correlation networks specific to clinical and biochemical covariate show differences associated with sexual dimorphism in a cohort of nonagenarians

  2021cites this paper
• Prediagnostic circulating metabolites in female breast cancer cases with low and high mammographic breast density

  2021cites this paper
• A Serum Metabolomics Classifier Derived from Elderly Patients with Metastatic Colorectal Cancer Predicts Relapse in the Adjuvant Setting

  2021cites this paper
• Precision Oncology via NMR-Based Metabolomics: A Review on Breast Cancer

  2021influential citation
• Differential Network Analysis Reveals Metabolic Determinants Associated with Mortality in Acute Myocardial Infarction Patients and Suggests Potential Mechanisms Underlying Different Clinical Scores Used To Predict Death

  2020cites this paper
• Effect of Estrogen Receptor Status on Circulatory Immune and Metabolomics Profiles of HER2-Positive Breast Cancer Patients Enrolled for Neoadjuvant Targeted Chemotherapy

  2020cites this paper
• Metabolome of Pancreatic Juice Delineates Distinct Clinical Profiles of Pancreatic Cancer and Reveals a Link between Glucose Metabolism and PD-1+ Cells

  2020cites this paper
• Fingerprinting Alzheimer's Disease by 1H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal Fluid.

  2020cites this paper
• Evaluation of MDA-MB-468 Cell Culture Media Analysis in Predicting Triple-Negative Breast Cancer Patient Sera Metabolic Profiles

  2020cites this paper
• Metabolomic Profiling for Diagnosis and Prognostication in Surgery: A Scoping Review.

  2020cites this paper
• Optimization and validation of a HILIC-LC-ESI-MS/MS method for the simultaneous analysis of targeted metabolites: Cross validation of untargeted metabolomic studies for early diagnosis of breast cancer

  2020cites this paper
• Metabolomics to Assess Response to Immune Checkpoint Inhibitors in Patients with Non-Small-Cell Lung Cancer

  2020cites this paper
• Differential Network Analysis Reveals Molecular Determinants Associated with Blood Pressure and Heart Rate in Healthy Subjects

  2020cites this paper
• Plasma metabolites as possible biomarkers for diagnosis of breast cancer

  2019cites this paper
• NMR‐based metabolomics of biofluids in cancer

  2019cites this paper
• Serum biomarkers of the calcium-deficient rats identified by metabolomics based on UPLC/Q-TOF MS/MS

  2019cites this paper
• Serum levels of inflammation‐related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers

  2019cites this paper
• The applications of metabolomics in the molecular diagnostics of cancer

  2019cites this paper
• The effect of data integration on LC-MS-based metabolomics data: evaluation on the comparative classification capacities

  2019cites this paper
• NMR for sample quality assessment in metabolomics.

  2019cites this paper
• Uniqueness of the NMR approach to metabolomics

  2019cites this paper
• Current Status and Future Prospects of Clinically Exploiting Cancer-specific Metabolism—Why Is Tumor Metabolism Not More Extensively Translated into Clinical Targets and Biomarkers?

  2019cites this paper
• Assessing the Effectiveness of Direct Data Merging Strategy in Long-Term and Large-Scale Pharmacometabonomics

  2019influential citation
• Breast cancer risk in relation to plasma metabolites among Hispanic and African American women

  2019cites this paper
• Biomarker Discovery for Immunotherapy of Pituitary Adenomas: Enhanced Robustness and Prediction Ability by Modern Computational Tools

  2019cites this paper
• NMR-based metabolomics identifies patients at high risk of death within two years after acute myocardial infarction in the AMI-Florence II cohort

  2019cites this paper
• Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification

  2019cites this paper
• Assessing treatment response and prognosis by serum and tissue metabolomics in breast cancer patients.

  2019cites this paper
• Metabolomics: a promising diagnostic and therapeutic implement for breast cancer

  2019cites this paper
• Panoptic View of Prognostic Models for Personalized Breast Cancer Management

  2019cites this paper
• NMR-based metabolomics for the assessment of inhaled pharmacotherapy in Chronic Obstructive Pulmonary Disease patients.

  2019cites this paper
• Masterthesis Prediction of therapy response in lung cancer patients : Optimization and evaluation of a robust 1 H-NMR metabolomics protocol 2018 • 2019

  2019cites this paper
• OTT_A_215628 6797..6811

  2019cites this paper
• Estimating the magnitude of clinical benefit from (neo)adjuvant chemotherapy in patients with ER-positive/HER2-negative breast cancer.

  2019cites this paper
• A Review on Metabolomics Data Analysis for Cancer Applications

  2018cites this paper
• Clinical Relevance of Immune Cells in Pancreatic Adenocarcinoma and their Implication in Immunotherapy

  2018cites this paper
• Diagnosis of Breast Cancer Using Candidate Metabolomic Biomarkers

  2018cites this paper
• Evaluation and comparison of bioinformatic tools for the enrichment analysis of metabolomics data

  2018cites this paper
• Metabolomics in breast cancer: A decade in review.

  2018cites this paper
• Diagnosis of Lung Cancer: What Metabolomics Can Contribute

  2018cites this paper
• Identification and functional analyses of differentially expressed metabolites in early stage endometrial carcinoma

  2018cites this paper
• Taurine, glutamic acid and ethylmalonic acid as important metabolites for detecting human breast cancer based on the targeted metabolomics

  2018cites this paper
• Metabolomics: A High-Throughput Platform for Metabolite Profile Exploration.

  2018cites this paper
• A Metabolomic Approach to Predict Breast Cancer Behavior and Chemotherapy Response

  2018cites this paper
• Metabolic fingerprinting in breast cancer stages through 1H NMR spectroscopy‐based metabolomic analysis of plasma

  2018cites this paper
• 1 NMR based metabolomics of biofluids in cancer

  2018cites this paper
• Identification of metabolic phenotypes in childhood obesity by 1H NMR metabolomics of blood plasma

  2018cites this paper
• High‐Throughput Metabolomics by 1D NMR

  2018cites this paper
• Metabolic Signature of Primary Biliary Cholangitis and Its Comparison with Celiac Disease.

  2018cites this paper
• Application of NMR metabolomics to search for human disease biomarkers in blood

  2018cites this paper
• Hochdurchsatz‐Metabolomik mit 1D‐NMR

  2018cites this paper
• Automated metabolite identification from biological fluid 1H NMR spectra

  2017cites this paper
• De-escalating and escalating treatment beyond endocrine therapy in patients with luminal breast cancer.

  2017cites this paper
• Does the 1H-NMR plasma metabolome reflect the host-tumor interactions in human breast cancer?

  2017influential citation